Mesenchymal Stem Cell Therapy for Prader-Willi Syndrome

  • Susanti Pada Vinski D
  • Cinta Vinski N
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

This study observed the effectiveness of UC-MSC Stem Cells in alleviating Prader-Willi syndromes. One good reason was that UC-MSC with a wide variety of stem cells is well-sourced and easy to collect and preserve. It also has the capability of multi-directional differentiation. It can differentiate into bone, adipose, cartilage, and other tissues and meet this endeavor's intended purpose. Besides it, UC-MSC is also the product of Celltech Stem Cell Laboratory & Banking (CSC) where this study is initiated. Experiments were applied on patients of different sexes to see the results of the treatments where both meet satisfactory expectations.

Cite

CITATION STYLE

APA

Susanti Pada Vinski, D., & Cinta Vinski, N. (2023). Mesenchymal Stem Cell Therapy for Prader-Willi Syndrome. International Journal of Social Health, 2(4), 129–135. https://doi.org/10.58860/ijsh.v2i4.33

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free